Paloma Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-77,500
Closed -$7.81M 802
2023
Q4
$7.81M Buy
+77,500
New +$7.69M 0.29% 54
2023
Q1
Sell
-8,300
Closed -$638K 774
2022
Q4
$638K Buy
+8,300
New +$631K 0.03% 461
2019
Q2
Sell
-19,600
Closed -$944K 1756
2019
Q1
$944K Buy
19,600
+8,600
+78% +$431K 0.02% 755
2018
Q4
$491K Sell
11,000
-500
-4% -$26.1K 0.02% 684
2018
Q3
$621K Sell
11,500
-9,300
-45% -$476K 0.01% 938
2018
Q2
$1.02M Buy
20,800
+14,900
+253% +$845K 0.02% 715
2018
Q1
$370K Buy
+5,900
New +$405K 0.01% 1523
2017
Q4
Sell
-46,200
Closed -$3.09M 1907
2017
Q3
$3.09M Buy
+46,200
New +$3.27M 0.04% 475

Other funds holding CAH

Paloma Partners's CAH Position: Q2 2025 in Review

Paloma Partners sold out of Cardinal Health (CAH) in Q2 2025, closing a stake of 6,815 shares — an estimated $939K sold.

Paloma Partners first reported a position in CAH in Q2 2013 and held it in 36 quarters. The position peaked at $10.4M in Q4 2021. 1,254 funds tracked by Wall St. Rank hold CAH as of Q2 2025.

  • Paloma Partners reported no remaining Cardinal Health position as of Q2 2025 after selling out during the quarter.
  • Paloma Partners sold 6,815 Cardinal Health shares in Q2 2025, an estimated $939K.
  • Paloma Partners first reported a position in Cardinal Health in Q2 2013 and held it in 36 quarters.
  • Paloma Partners's Cardinal Health position peaked at $10.4M in Q4 2021.
  • 1,254 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.